Search Results - "Nussenzweig, Michel C."
-
1
Germinal Centers
Published in Annual review of immunology (26-04-2022)“…Germinal centers (GCs) are microanatomical sites of B cell clonal expansion and antibody affinity maturation. Therein, B cells undergo the Darwinian process of…”
Get full text
Journal Article -
2
Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic
Published in Nature medicine (01-04-2019)“…Combination anti-retroviral therapy (ART) has revolutionized the treatment and prevention of HIV-1 infection. Taken daily, ART prevents and suppresses the…”
Get full text
Journal Article -
3
Germinal Centers
Published in Annual review of immunology (01-01-2012)“…Germinal centers (GCs) were described more than 125 years ago as compartments within secondary lymphoid organs that contained mitotic cells. Since then, it has…”
Get full text
Journal Article -
4
Plasma Neutralization of the SARS-CoV-2 Omicron Variant
Published in The New England journal of medicine (10-02-2022)“…Neutralization assays of SARS-CoV-2 pseudoviruses expressing wild-type, omicron, or a synthetic resistant spike protein in plasma drawn from 47 people over…”
Get full text
Journal Article -
5
Origin and development of dendritic cells
Published in Immunological reviews (01-03-2010)“…Dendritic cells (DCs) are specialized antigen-presenting cells and essential mediators of immunity and tolerance. This group of cells is heterogeneous in terms…”
Get full text
Journal Article -
6
Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity
Published in Cell (11-09-2014)“…Broadly neutralizing antibodies (bNAbs) against HIV-1 provide both effective pre-exposure prophylaxis and treatment of HIV-1 infection in murine and nonhuman…”
Get full text
Journal Article -
7
Origin of Chromosomal Translocations in Lymphoid Cancer
Published in Cell (02-04-2010)“…Aberrant fusions between heterologous chromosomes are among the most prevalent cytogenetic abnormalities found in cancer cells. Oncogenic chromosomal…”
Get full text
Journal Article -
8
Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization
Published in Cell (28-03-2013)“…Broadly neutralizing antibodies (bNAbs) to HIV-1 can prevent infection and are therefore of great importance for HIV-1 vaccine design. Notably, bNAbs…”
Get full text
Journal Article -
9
Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy
Published in Cell (13-02-2014)“…Despite 30 years of effort, there is no effective vaccine for HIV-1. However, antibodies can prevent HIV-1 infection in humanized mice and macaques when…”
Get full text
Journal Article -
10
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Published in Nature (London) (24-12-2020)“…The coronavirus disease 2019 (COVID-19) pandemic presents an urgent health crisis. Human neutralizing antibodies that target the host ACE2 receptor-binding…”
Get full text
Journal Article -
11
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Published in The Journal of experimental medicine (02-11-2020)“…The emergence of SARS-CoV-2 and the ensuing explosive epidemic of COVID-19 disease has generated a need for assays to rapidly and conveniently measure the…”
Get full text
Journal Article -
12
Protein Amounts of the MYC Transcription Factor Determine Germinal Center B Cell Division Capacity
Published in Immunity (Cambridge, Mass.) (20-08-2019)“…High-affinity B cell selection in the germinal center (GC) is governed by signals delivered by follicular helper T (Tfh) cells to B cells. Selected B cells…”
Get full text
Journal Article -
13
Antibody Affinity Shapes the Choice between Memory and Germinal Center B Cell Fates
Published in Cell (25-11-2020)“…Immunological memory is required for protection against repeated infections and is the basis of all effective vaccines. Antibodies produced by memory B cells…”
Get full text
Journal Article -
14
High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape
Published in Nature (London) (16-12-2021)“…The number and variability of the neutralizing epitopes targeted by polyclonal antibodies in individuals who are SARS-CoV-2 convalescent and vaccinated are key…”
Get full text
Journal Article -
15
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
Published in Nature (London) (15-07-2021)“…More than one year after its inception, the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…”
Get full text
Journal Article -
16
Antibodies in HIV-1 Vaccine Development and Therapy
Published in Science (American Association for the Advancement of Science) (13-09-2013)“…Despite 30 years of study, there is no HIV-1 vaccine and, until recently, there was little hope for a protective immunization. Renewed optimism in this area of…”
Get full text
Journal Article -
17
Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
Published in Science (American Association for the Advancement of Science) (12-02-2021)“…Protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and SARS-related emergent zoonotic coronaviruses is urgently needed. We made…”
Get full text
Journal Article -
18
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
Published in Cell (20-08-2020)“…Neutralizing antibody responses to coronaviruses mainly target the receptor-binding domain (RBD) of the trimeric spike. Here, we characterized polyclonal…”
Get full text
Journal Article -
19
Translocation-Capture Sequencing Reveals the Extent and Nature of Chromosomal Rearrangements in B Lymphocytes
Published in Cell (30-09-2011)“…Chromosomal rearrangements, including translocations, require formation and joining of DNA double strand breaks (DSBs). These events disrupt the integrity of…”
Get full text
Journal Article -
20
Early antibody therapy can induce long-lasting immunity to SHIV
Published in Nature (London) (23-03-2017)“…Early administration of broadly neutralizing antibodies in a macaque SHIV infection model is associated with very low levels of persistent viraemia, which…”
Get full text
Journal Article